Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 231 results found. Search for [ Glenmark Pharmaceuticals ]

Results 1 to 21 of 231
PTI
November 26, 2019
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


PTI
October 9, 2019



BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


BusinessToday.In
New Delhi, September 28, 2019
As per the proposal, Glenmark Pharma plans to raise up to $200 million in Indian and/or international market through bonds, debentures or other debt securities in one or more tranches


PTI
September 10, 2019



PTI
August 24, 2019



PTI
August 19, 2019



PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


BusinessToday.In
New Delhi, July 11, 2019
As per the agreement, Glenmark will receive an upfront payment, licence fees and royalties for the non-exclusive sub-license rights from Torrent


PTI
July 11, 2019



PTI
July 11, 2019



PTI
June 28, 2019



BusinessToday.In
June 24, 2019
Glenmark Pharma's shares opened 5 points down at Rs 495 after forming a gap down chart pattern at the opening bell, against the last close of Rs 500


PTI
June 24, 2019



PTI
June 20, 2019



BusinessToday.In
May 30, 2019
Share Market Updates: Suzlon, Justdial, Infibeam, DCM Shriram and Adani Power were the top gainers on BSE, while on NSE, YES Bank, Bharti Airtel, NTPC, TCS and Bajaj Finance were the top gaining stocks.


PTI
May 29, 2019



PTI
May 27, 2019



E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


PAGES 1 OF 12  12345